Intravesical bacillus Calmette-Guerin in the treatment of recurrent superficial bladder tumors

Seven patients with recurrent superficial bladder tumors were treated by vesical and intradermal administration of BCG. All of these patients have had recurrence more than 2 times. BCG instillation was performed every weeks for 6 weeks after transurethral resection of bladder tumor. A suspension con...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 34(1988), 6 vom: 31. Juni, Seite 983-6
1. Verfasser: Nakano, M (VerfasserIn)
Weitere Verfasser: Iwamuro, S, Fujii, H, Kondoh, I
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1988
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article BCG Vaccine
LEADER 01000naa a22002652 4500
001 NLM032047711
003 DE-627
005 20231221121616.0
007 tu
008 231221s1988 xx ||||| 00| ||jpn c
028 5 2 |a pubmed24n0107.xml 
035 |a (DE-627)NLM032047711 
035 |a (NLM)3223463 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a jpn 
100 1 |a Nakano, M  |e verfasserin  |4 aut 
245 1 0 |a Intravesical bacillus Calmette-Guerin in the treatment of recurrent superficial bladder tumors 
264 1 |c 1988 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 21.03.1989 
500 |a Date Revised 15.11.2006 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Seven patients with recurrent superficial bladder tumors were treated by vesical and intradermal administration of BCG. All of these patients have had recurrence more than 2 times. BCG instillation was performed every weeks for 6 weeks after transurethral resection of bladder tumor. A suspension containing 120 mg BCG in 40 ml normal saline was instilled intravesically. BCG was administered into alternate upper thighs using a multiple puncture apparatus. Statistical analysis of bladder tumor in our hospital revealed the second recurrence rate to be 73.2%. The reduction of tumor recurrence rate of BCG treated patients was 43.0%. The reduction of tumor recurrence by BCG treatment was statistically significant, compared to other treatments. It seemed that patients with severe side effects such as bladder tenesmus and urinary infection, have a long tumor-free period. Therefore, we suggest that the reactive inflammation in bladder during BCG treatment plays an important role 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 7 |a BCG Vaccine  |2 NLM 
700 1 |a Iwamuro, S  |e verfasserin  |4 aut 
700 1 |a Fujii, H  |e verfasserin  |4 aut 
700 1 |a Kondoh, I  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Hinyokika kiyo. Acta urologica Japonica  |d 1962  |g 34(1988), 6 vom: 31. Juni, Seite 983-6  |w (DE-627)NLM012631779  |x 0018-1994  |7 nnns 
773 1 8 |g volume:34  |g year:1988  |g number:6  |g day:31  |g month:06  |g pages:983-6 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_350 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2018 
951 |a AR 
952 |d 34  |j 1988  |e 6  |b 31  |c 06  |h 983-6